TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today...
Orchard Therapeutics is an England-based biotechnology company that develops and commercializes stem cell therapies for the treatment of genetic diseases.